Clinical impact of Ocrelizumab extended interval dosing during the COVID-19 pandemic and associations with CD19+ B-cell repopulation
| Autor: | Sahi, Nitin Kumar, Abidi, Syed Muhammad Ali, Salim, Omar, Abraham, Roby, Kalra, Seema, Al-Araji, Adnan |
|---|---|
| Zdroj: | In Multiple Sclerosis and Related Disorders September 2021 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect